CD97 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD97 monoclonal antibodies for research focused on understanding this important protein. CD97 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD97 is a member of the EGF-TM7 family of receptors and plays a crucial role in cell adhesion, migration, and immune response regulation. CD97 expression is associated with various physiological and pathological processes, including inflammation and cancer progression. Research has shown that CD97 is highly expressed in immune cells and can influence their behavior during inflammatory responses. CD97 has emerged as a potential therapeutic target due to its involvement in multiple disease pathways. Understanding CD97's molecular mechanisms and signaling pathways can reveal new therapeutic strategies for treating various conditions. Investigating CD97's role in different cellular processes may uncover novel approaches for disease intervention. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CD97's role in health and disease.